?
Home
About
Company Overview
History
Group Structure
Activity Photos
Handa US
R&D
Technology Platform
505(b)(2) NDA
High Barrier ANDA
Corporate
Board of Directors
Committee
Internal Audit
Major Internal Policies
Investor
Company Profile
Financials
Shareholders’ Services
Stakeholder
News
Announcement
Contact
Location
Join Us
Home
About
Company Overview
History
Group Structure
Activity Photos
Handa US
R&D
Technology Platform
505(b)(2) NDA
High Barrier ANDA
Corporate
Board of Directors
Committee
Internal Audit
Major Internal Policies
Investor
Company Profile
Financials
Shareholders’ Services
Stakeholder
News
Announcement
Contact
Location
Join Us
R&D
HND-026
Indication
GI drug
Status
Batch Manufacture ongoing.
Product Advantages
ANDA product
Potential Market
The drug market value of related disease is about $6.6 billion in 2022.
